What’s the Buzz – February

by | Feb 18, 2016 | Clinical Care, Fibromyalgia, ME/CFS, Patient Education, Research News

Buzz - January 2017

EWhatstheBuzzach month we scour the Internet and bring you a list of news articles, blogs and research publications we think you’ll find interesting for our What’s the Buzz post. Occasionally, we’ll highlight and summarize a few of them for you, like these:


A new paper co-authored by Drs. Vernon, Deftereos and Persidis at aimed at understanding the “clinical intuition” doctors use to manage and treat ME/CFS patients would help identify ways to accelerate FDA-approved treatments.  The results are published in the January issue of Fatigue: Biomedicine, Health & Behavior and contains treatment information that may be of interest to your doctor.

Access it HERE & Read our blog about it HERE


Earlier this month, the CDC’s Grand Rounds focused on ME/CFS. For individuals who were unable to view the session during the scheduled time, the archived presentation will be posted by Friday, February 19, 2016.


This is an excellent resource for any member of your medical team, so pass it along.


Allison Dunne announced on 2/11/2016 NIH grants through NINDS totaling $500,000 for CFS in adolescents and young adults and for a strep study.


On 1/18/2016 NIH announced a grant through NINDS totaling $246,000 for reducing orthostatic intolerance with oral rehydration on patient with ME/CFS


February 10, 2016, by Patricia Inacio, PhD – Mitochondrial DNA Variations May Spur Symptoms in People with Form of Chronic Fatigue



February 16, 2016, HealthDay – A new study finds that Acupuncture May Help Ease Fibromyalgia Pain



February 14, 2016, Sue Ingebretson – A new post on ProHealth discusses the possible health benefits of chocolate and what new research may be saying about its positive effects for those dealing with Fibromyalgia.



February 4, 2016, Llewellyn King, on InsideSources.com “… Myalgic Encephalomyelitis, also known as Chronic Fatigue Syndrome. Compared to any other disease affecting a large number of people (1 million victims of ME/CFS in the United States, according to the Centers For Disease Control), it has been funded so little by the government as to amount to willful neglect. It receives a miniscule $5 million a year in funding.”